Requests For Proposals (RFPs)
Accelerating DRUG DISCOVERY for Frontotemporal Degeneration
Deadline: September 22, 2015
Research investigating the pathologic mechanisms underlying frontotemporal degeneration (FTD) is advancing, creating new targets for drug discovery. As potential therapies move forward, the need for biomarkers for early diagnosis, to distinguish FTD subtypes, and to monitor disease progression is also critical. The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) seek to accelerate and support innovative drug discovery programs and biomarker development for FTD through this Request for Proposals (RFP).
AFTD Pilot Grants
Deadline: July 31, 2015 – Seeking competitive proposals up to a maximum of $60,000
AFTD Pilot Grants are intended to support early career investigators and to provide seed funds for new and creative ideas that address critical issues in FTD research. Funded investigators are encouraged to use the preliminary data generated in a pilot grant toward larger public or private grant applications that will further our understanding of the FTD disorders.
For our 2015 Pilot Grants, AFTD is seeking grant applications that address basic science or clinical research questions in FTD. At the discretion of our Board of Directors, AFTD will fund up to 2 pilot studies—one for basic science research, and one for clinical research that has been made possible by the Susan Marcus Memorial Fund.
Grants will be awarded for one year duration, with a maximum funding amount of $60,000 per grant, for direct costs only. Applications may be submitted by investigators at nonprofit academic/hospital research institutions worldwide.
Deadline for Submission of Applications: Friday, July 31, 2015